WEBSITE BSE:506532 NSE: NITTA GELA Inc. Year: 1975 Industry: Chemicals My Bucket: Add Stock
Last updated: 15:42
Nitta Gelatin India Ltd is engaged in the manufacture and sale of Di Calcium Phosphate (DCP), Collagen Peptide, Gelatin, Ossein. It's geographic segments encompass Domestic and Export. It's products also include NutriGold, CartiPep, Ossein (Limed), and Chitosan. Collagen Peptide is utilized in diverse packages, together with healthcare, private care and food merchandise. The Company resources DCP to poultry farms and animal feed manufacturers in India. Chitosan is used in numerous industries, such as pharmaceutical, clinical, cosmetic, meals an...Read More
Nitta Gelatin India Ltd is engaged in the manufacture and sale of Di Calcium Phosphate (DCP), Collagen Peptide, Gelatin, Ossein. It's geographic segments encompass Domestic and Export. It's products also include NutriGold, CartiPep, Ossein (Limed), and Chitosan. Collagen Peptide is utilized in diverse packages, together with healthcare, private care and food merchandise. The Company resources DCP to poultry farms and animal feed manufacturers in India. Chitosan is used in numerous industries, such as pharmaceutical, clinical, cosmetic, meals and agriculture, textile and water treatment. CartiPep is a system of Bioactive Collagen Peptides, Glucosamine hydrochloride (HCl) and Vitamin C. The Company's aid services encompass after-sales guidance, technical recommendation and utilization-associated solutions. The Company's plant life are positioned at Koratty, Trichur District, Kerala; Kusumagiri, Ernakulam District, Kerala, and CherthalaTaluk, Alappuzha, Kerala. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹840 Cr.
Stock P/E 10
P/B 1.8
Current Price ₹925.5
Book Value ₹ 526
Face Value 10
52W High ₹1005
Dividend Yield 0.86%
52W Low ₹ 735
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 140 | 134 | 130 | 130 | 132 | 135 | 129 | 139 | 138 | 150 |
| Other Income | 3 | 0 | 5 | 2 | 4 | 3 | 3 | 2 | 4 | 1 |
| Total Income | 143 | 135 | 136 | 133 | 137 | 137 | 133 | 141 | 142 | 151 |
| Total Expenditure | 108 | 102 | 110 | 102 | 107 | 107 | 106 | 111 | 112 | 112 |
| Operating Profit | 34 | 33 | 25 | 31 | 30 | 30 | 26 | 30 | 30 | 39 |
| Interest | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 4 | 4 | 4 | 3 | 3 | 3 | 4 | 3 | 4 | 4 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 7 | 4 | 0 | 0 | 0 |
| Profit Before Tax | 30 | 29 | 20 | 27 | 27 | 33 | 26 | 26 | 26 | 35 |
| Provision for Tax | 8 | 8 | 6 | 7 | 6 | 8 | 6 | 7 | 7 | 10 |
| Profit After Tax | 22 | 21 | 13 | 20 | 20 | 25 | 20 | 20 | 19 | 26 |
| Adjustments | -1 | -1 | 1 | -1 | 0 | -0 | -0 | -0 | -0 | -0 |
| Profit After Adjustments | 21 | 20 | 14 | 20 | 20 | 24 | 20 | 19 | 18 | 26 |
| Adjusted Earnings Per Share | 23.4 | 21.9 | 15.4 | 21.7 | 22.3 | 26.9 | 21.6 | 21.1 | 20.3 | 28.2 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 357 | 359 | 356 | 342 | 303 | 342 | 396 | 506 | 565 | 533 | 533 | 556 |
| Other Income | 2 | 2 | 9 | 5 | 1 | 2 | 1 | 5 | 1 | 11 | 12 | 10 |
| Total Income | 360 | 361 | 365 | 347 | 304 | 344 | 398 | 511 | 566 | 544 | 545 | 567 |
| Total Expenditure | 334 | 322 | 320 | 313 | 273 | 306 | 351 | 442 | 452 | 409 | 429 | 441 |
| Operating Profit | 26 | 38 | 45 | 34 | 31 | 37 | 46 | 69 | 114 | 134 | 116 | 125 |
| Interest | 10 | 8 | 7 | 7 | 9 | 8 | 6 | 5 | 4 | 3 | 2 | 0 |
| Depreciation | 14 | 13 | 14 | 15 | 15 | 16 | 16 | 14 | 14 | 15 | 14 | 15 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 12 | 4 |
| Profit Before Tax | 1 | 18 | 24 | 12 | 7 | 13 | 25 | 49 | 99 | 116 | 112 | 113 |
| Provision for Tax | 5 | 10 | 12 | 7 | 2 | 1 | 7 | 14 | 25 | 32 | 28 | 30 |
| Profit After Tax | -4 | 9 | 12 | 5 | 5 | 12 | 18 | 35 | 74 | 84 | 84 | 85 |
| Adjustments | 2 | 2 | 2 | -0 | -1 | -1 | -1 | -2 | -4 | -1 | -0 | 0 |
| Profit After Adjustments | -1 | 11 | 14 | 4 | 3 | 11 | 17 | 33 | 70 | 83 | 84 | 83 |
| Adjusted Earnings Per Share | -1.6 | 11 | 15.6 | 4.9 | 3.8 | 12.4 | 19.1 | 36.3 | 77.4 | 91 | 92.5 | 91.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 0% | 2% | 9% | 4% |
| Operating Profit CAGR | -13% | 19% | 26% | 16% |
| PAT CAGR | 0% | 34% | 48% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 17% | 3% | 42% | 16% |
| ROE Average | 22% | 27% | 22% | 13% |
| ROCE Average | 28% | 33% | 26% | 17% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 108 | 130 | 134 | 149 | 151 | 153 | 173 | 201 | 268 | 343 | 422 |
| Minority's Interest | 6 | 4 | 3 | 1 | 3 | 3 | 3 | 4 | 7 | 7 | 7 |
| Borrowings | 19 | 34 | 40 | 38 | 34 | 29 | 23 | 7 | 7 | 4 | 4 |
| Other Non-Current Liabilities | 10 | 10 | 15 | 5 | 4 | -0 | 5 | 9 | 3 | 5 | 7 |
| Total Current Liabilities | 80 | 78 | 110 | 114 | 122 | 107 | 103 | 125 | 83 | 63 | 75 |
| Total Liabilities | 223 | 256 | 301 | 306 | 313 | 292 | 306 | 345 | 367 | 423 | 515 |
| Fixed Assets | 118 | 120 | 110 | 113 | 130 | 121 | 113 | 107 | 114 | 114 | 117 |
| Other Non-Current Assets | 14 | 14 | 35 | 43 | 34 | 36 | 29 | 34 | 32 | 38 | 57 |
| Total Current Assets | 91 | 122 | 156 | 150 | 149 | 135 | 165 | 204 | 221 | 270 | 341 |
| Total Assets | 223 | 256 | 301 | 306 | 313 | 292 | 306 | 345 | 367 | 423 | 515 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 2 | 1 | 4 | 3 | 5 | 1 | 1 | 2 | 30 | 34 |
| Cash Flow from Operating Activities | 20 | 20 | 11 | 27 | 22 | 40 | 19 | 17 | 101 | 94 | 75 |
| Cash Flow from Investing Activities | -8 | -14 | -3 | -7 | -14 | -10 | -7 | -14 | -18 | -54 | -9 |
| Cash Flow from Financing Activities | -12 | 18 | -5 | -20 | -7 | -33 | -12 | -2 | -55 | -36 | 11 |
| Net Cash Inflow / Outflow | 0 | 25 | 3 | -0 | 1 | -3 | -0 | 1 | 28 | 4 | 77 |
| Closing Cash & Cash Equivalent | 2 | 27 | 4 | 3 | 5 | 1 | 1 | 2 | 30 | 34 | 112 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -1.56 | 10.95 | 15.6 | 4.91 | 3.82 | 12.38 | 19.15 | 36.26 | 77.44 | 91.02 | 92.46 |
| CEPS(Rs) | 11.84 | 23.49 | 28.58 | 21.62 | 21.95 | 30.82 | 36.85 | 54.21 | 96.95 | 109.32 | 108.54 |
| DPS(Rs) | 1 | 2.5 | 2.5 | 2.5 | 1.5 | 2.5 | 3 | 4 | 7.5 | 6 | 8 |
| Book NAV/Share(Rs) | 119.13 | 126.01 | 147.09 | 163.61 | 165.83 | 168.9 | 190.58 | 221.25 | 294.75 | 378.26 | 464.7 |
| Core EBITDA Margin(%) | 6.33 | 9.75 | 10.02 | 8.46 | 9.96 | 10.43 | 11.33 | 12.68 | 20.04 | 23.09 | 19.46 |
| EBIT Margin(%) | 3.02 | 6.93 | 8.71 | 5.42 | 5.31 | 6.35 | 7.78 | 10.75 | 18.22 | 22.35 | 21.22 |
| Pre Tax Margin(%) | 0.38 | 4.89 | 6.74 | 3.46 | 2.41 | 3.9 | 6.37 | 9.69 | 17.48 | 21.79 | 20.91 |
| PAT Margin (%) | -0.97 | 2.31 | 3.44 | 1.34 | 1.62 | 3.6 | 4.51 | 6.87 | 13.04 | 15.75 | 15.73 |
| Cash Profit Margin (%) | 2.9 | 5.75 | 7.3 | 5.72 | 6.56 | 8.15 | 8.42 | 9.71 | 15.53 | 18.59 | 18.44 |
| ROA(%) | -1.6 | 3.57 | 4.39 | 1.52 | 1.59 | 4.08 | 5.99 | 10.69 | 20.75 | 21.3 | 17.93 |
| ROE(%) | -3.31 | 7.69 | 9.87 | 3.26 | 3.29 | 8.13 | 10.99 | 18.64 | 31.55 | 27.53 | 21.97 |
| ROCE(%) | 6.38 | 13.52 | 13.8 | 7.52 | 6.32 | 8.8 | 12.61 | 20.19 | 34.77 | 35.93 | 27.99 |
| Receivable days | 21.93 | 20.95 | 37.36 | 60.6 | 75.09 | 51.93 | 44.48 | 54.47 | 56.87 | 59.14 | 61.5 |
| Inventory Days | 53.06 | 57.33 | 69.42 | 78.01 | 85.78 | 85.65 | 84.61 | 70.37 | 63.02 | 64.75 | 64.3 |
| Payable days | 51.98 | 46.66 | 46.04 | 52.11 | 64.1 | 48.7 | 40.09 | 30.09 | 33.55 | 45.11 | 39.72 |
| PER(x) | 0 | 18.65 | 12.23 | 40.59 | 32.97 | 7.21 | 8.71 | 7.8 | 11.48 | 9.17 | 7.09 |
| Price/Book(x) | 1.06 | 1.62 | 1.3 | 1.22 | 0.76 | 0.53 | 0.88 | 1.28 | 3.02 | 2.21 | 1.41 |
| Dividend Yield(%) | 0.79 | 1.22 | 1.31 | 1.26 | 1.19 | 2.8 | 1.8 | 1.41 | 0.84 | 0.72 | 1.22 |
| EV/Net Sales(x) | 0.5 | 0.7 | 0.75 | 0.81 | 0.71 | 0.48 | 0.58 | 0.67 | 1.44 | 1.31 | 0.91 |
| EV/Core EBITDA(x) | 6.98 | 6.51 | 5.97 | 8.24 | 6.95 | 4.34 | 4.93 | 4.93 | 7.13 | 5.17 | 4.2 |
| Net Sales Growth(%) | 23.57 | 0.32 | -0.79 | -3.82 | -11.43 | 12.91 | 15.81 | 27.69 | 11.74 | -5.77 | -0 |
| EBIT Growth(%) | 2302.47 | 129.86 | 20.43 | -39.97 | -13.21 | 35.19 | 41.66 | 76.42 | 89.34 | 15.6 | -4.99 |
| PAT Growth(%) | 45.22 | 338.78 | 42.91 | -62.4 | 7 | 150.9 | 45.17 | 94.37 | 112.07 | 13.81 | -0.06 |
| EPS Growth(%) | 76.71 | 801.36 | 42.48 | -68.55 | -22.08 | 223.86 | 54.65 | 89.36 | 113.58 | 17.54 | 1.57 |
| Debt/Equity(x) | 0.61 | 0.59 | 0.81 | 0.7 | 0.72 | 0.55 | 0.46 | 0.43 | 0.15 | 0.04 | 0.07 |
| Current Ratio(x) | 1.14 | 1.56 | 1.41 | 1.32 | 1.22 | 1.26 | 1.6 | 1.64 | 2.68 | 4.27 | 4.58 |
| Quick Ratio(x) | 0.46 | 0.78 | 0.74 | 0.68 | 0.65 | 0.41 | 0.7 | 0.82 | 1.55 | 2.75 | 3.35 |
| Interest Cover(x) | 1.14 | 3.4 | 4.43 | 2.77 | 1.83 | 2.6 | 5.53 | 10.17 | 24.8 | 40.32 | 68.33 |
| Total Debt/Mcap(x) | 0.57 | 0.41 | 0.63 | 0.57 | 0.94 | 1.03 | 0.53 | 0.34 | 0.05 | 0.02 | 0.05 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.48 | 74.48 | 74.48 | 74.48 | 74.48 | 74.48 | 74.48 | 74.48 | 74.48 | 74.48 |
| FII | 0 | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.11 | 0.11 | 0.11 | 0.11 | 0.08 | 0.09 | 0.35 | 0.64 | 0.74 | 0.92 |
| Public | 25.4 | 25.4 | 25.39 | 25.4 | 25.44 | 25.43 | 25.16 | 24.88 | 24.77 | 24.59 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 | 0.68 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 |
| Public | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | 0.22 | 0.22 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 | 0.91 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
